col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


59 Results       Page 1

 [1] 
Elsevier: Journal of Global Antimicrobial Resistance
  original article Date Title Authors   All Authors
1 [GO] 2024―May―23 A Scoping Review of Bacterial Resistance Among Inpatients Amidst the COVID-19 Pandemic Noora Reffat, Rebecca J Schwei, Meggie Griffin, Aurora Pop-Vicas, Lucas T Schulz, Michael S Pulia
2 [GO] 2024―May―07 Clinical characteristics and risk factors for bacterial co-infections in COVID-19 patients: A retrospective study Yichuan Gan, Guowen Zhang, Hengbiao Sun, Xiaoming Lyu
3 [GO] 2024―Mar―27 When it rains it pours: an increased prevalence of intestinal carriage of vancomycin-resistant Enterococcus faecium related to higher use of oral vancomycin in a tertiary care Hungarian clinical center during the years of the COVID-19 pandemic László Orosz
4 [GO] 2024―Mar―07 Changes in antimicrobial resistance of Escherichia coli isolated from community associated urinary tract infection before and during the COVID-19 pandemic in India Shwetha Venugopal, Sneha Chunchanur, Rajashree Panigrahy, Vibhor Tak, Manish Yadav, Akanksha Chauhan, et al. (+9)
5 [GO] 2024―Jan―26 Genomic surveillance of carbapenem-resistant Klebsiella pneumoniae reveals a prolonged outbreak of extensively drug-resistant ST147 NDM-1 during the COVID-19 pandemic in the Apulia region (Southern Italy) Daniela Loconsole, Anna Sallustio, Davide Sacco, Marilina Santantonio, Daniele Casulli, Domenico Gatti, et al. (+6)
6 [GO] 2024―Jan―03 An Evaluation of the Five Rights Antibiotic Safety Before and During COVID-19 at an NHS Foundation Trust in the United Kingdom Rasha Abdelsalam Elshenawy, Nkiruka Umaru, Zoe Aslanpour
7 [GO] 2023―Aug―22 Co-infection in COVID-19 patients performed microbiology detection: discovering multi-drug resistant microorganisms increased during the COVID-19 pandemic in Shanghai, China Xin Jin, Liyan Zeng, Lijun Zhang, Zhaoqin Zhu
8 [GO] 2023―Apr―13 Corrigendum to “Antibiotic expectation, behaviour, and receipt among patients presenting to emergency departments with uncomplicated upper respiratory tract infection during the COVID-19 pandemic” [Journal of Global Antimicrobial Resistance 33 (2023) 89-96] Zhilian Huang, Win Sen Kuan, Hann Yee Tan, Eillyne Seow, Ling Tiah, Li Lee Peng, et al. (+2)
9 [GO] 2023―Mar―10 Antibiotic expectation, behaviour, and receipt among patients presenting to emergency departments with uncomplicated upper respiratory tract infection during the COVID-19 pandemic Zhilian Huang, Win Sen Kuan, Hann Yee Tan, Eillyne Seow, Ling Tiah, Li Lee Peng, et al. (+2)
10 [GO] 2022―Dec―23 Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial Florian Kurth, Elisa T. Helbig, Lena J. Lippert, Charlotte Thibeault, Gianluca Barbone, Marius A. Eckart, et al. (+12)
11 [GO] 2022―Dec―19 61: SECONDARY INFECTION DURING THE THIRDWAVE OF COVID-19 IN A HOSPITAL IN KATHMANDU S.K. Mishra Baishnab
12 [GO] 2022―Dec―19 WS1.3: DETERMINANTS OF ANTIBIOTIC EXPECTATION AND RECEIPT AMONG PATIENTS PRESENTING TO EMERGENCY DEPARTMENTS WITH UPPER RESPIRATORY TRACT INFECTION DURING THE COVID-19 PANDEMIC Zhilian Huang, Angela Chow
13 [GO] 2022―Dec―19 WS1.2: USE OF ANTIBIOTICS IN COVID-19 PATIENTS AND ANTIBACTERIAL RESISTANCE PATTERN- A COUNTRYWIDE PICTURE Shrebash Paul, Tabiha Binte Hannan, T.M. Al-Amin, Md. Mohiuddin Khan, Binayak Bhattacharjee, Md. Zainal Abedin, et al. (+6)
14 [GO] 2022―Dec―19 63: A MICROBIOLOGICAL RETROSPECTIVE REVIEW OF BLOOD STREAM INFECTIONS IN COVID-19 PATIENTS FROM A TERTIARY CARE CENTER IN LEBANON S. Nahhal, N. Zahreddine, J. Tannous, N. Haddad, J. Zakhour, A. Shmoury, et al. (+3)
15 [GO] 2022―Dec―19 64: BACTERIAL RESPIRATORY INFECTIONS IN PATIENTS WITH COVID-19: A RETROSPECTIVE STUDY FROM A TERTIARY CARE CENTER IN LEBANON A. Shmoury, T. Sawma, S.F. Haddad, N. Zahreddine, J. Tannous, J. Zakhour, et al. (+2)
16 [GO] 2022―Dec―19 54: THE IMPACT OF THE CORONAVIRUS DISEASE PANDEMIC ON RESPIRATORY-RELATED INFECTIONS IN JAPAN D. Kitagawa, T. Kitano, M. Furumori, S. Suzuki, Y. Shintani, A. Nishiyama, et al. (+9)
17 [GO] 2022―Dec―19 58: SARS-COV-2 ANTIBODY CHARACTERISTICS OF SALIVA FROM VACCINATED INDIVIDUALS K. Ota, F. Mitsumoto-Kaseida, K. Sakamoto, K. Kosai, H. Hasegawa, K. Yamamoto, et al. (+4)
18 [GO] 2022―Dec―19 69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER M.V.R. Macatangay, J.A. Buensalido
19 [GO] 2022―Dec―01 Effect of Farnesyltransferase Inhibitors on SARS-CoV-2 Lea Weber, Lena Mautner, Mona Hoyos, Anja Ehrhardt, Armin Baiker, Hagen Sjard Bachmann
20 [GO] 2022―Nov―08 Replacement of KPC-producing pandemic lineages and dissemination of plasmids associated to antimicrobial resistance determinants during inpatient´s hospitalization Verónica E. Álvarez, Natalia García Allende, Mariana G. Massó, María Piekar, Josefina Campos, Barbara Fox, et al. (+4)
21 [GO] 2022―Oct―05 In vitro activity of ceftazidime/avibactam against carbapenem-non-susceptible Klebsiella penumoniae isolates collected during SARS-CoV-2 pandemic: a Southern Italy, multi-center, surveillance study Gianfranco La Bella, Teresa Lopizzo, Laura Lupo, Rosa Angarano, Anna Curci, Barbara Manti, et al. (+4)
22 [GO] 2022―Jun―13 Overuse of empirical antibiotics in a Covid-19 intensive care unit led to the spread of carbapenem-resistant Gram-negative bacteria in a teaching hospital Daniela Dambroso-Altafini, Silvia Maria dos Santos Saalfeld, Monica de Souza Ferreira de Mattos, Hilton Vizzi Martinez, Danielle Rosani Shinohara, Mirian Nicéa Zarpellon, et al. (+2)
23 [GO] 2022―Feb―25 Preexisting conditions among the SARS-CoV2 deaths during the SARS-CoV2 B.1.617.2 (Delta variant) outbreak in the United Kingdom Venkata R. Emani, Raghunath Reddy, Kartik K. Goswami, Abirath S. Nakka, Shaila R. Emani, Nikhila K. Reddy, et al. (+3)
24 [GO] 2022―Jan―14 In vitro evaluation of virucidal activity of disodium citrate perhydrate (2SCP) disinfectant against SARS-CoV-2 virus Géraldine Dessilly, Anne-thérèse Pâques, Anne-thérèse Vandenbroucke, Pierre Hazée, Alain Gaume, Katia Gindro, et al. (+3)
25 [GO] 2021―Nov―12 Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy Briony Adams, Alec Beaney
26 [GO] 2021―Nov―04 COVID-19 disease severity is linked to host immunity as well as lung and gut dysbiosis: a narrative review Nobuhiro Asai, Hiroshige Mikamo
27 [GO] 2021―Oct―28 Repatriation of patient with COVID-19 contributed to the importation of an emerging carbapenemase producer Aline I. Moser, Edgar I. Campos-Madueno, Parham Sendi, Vincent Perreten, Peter M. Keller, Alban Ramette, Andrea Endimiani
28 [GO] 2021―Sep―22 Successful prolonged cefiderocol treatment of a chronic left pleural empyema caused by Pseudomonas aeruginosa in a patient affected by COVID-19: a case report Luca Borghesi, Valentina Viaggi, Marco Franzetti, Matteo Montoli, Carola Mauri, Giovanni Moioli, et al. (+3)
29 [GO] 2021―Sep―04 Shortage in Appropriate Diagnostics of Antimicrobial Resistance in Lebanese Clinical Settings: A Crisis Amplified by COVID-19 and Economic Collapse Marwan Osman, Dalal Kasir, Issmat I. Kassem, Monzer Hamze
30 [GO] 2021―Jul―15 Loss of Function Mutations in the IFNAR2 in COVID-19 Severe Infection Susceptibility Sandra P. Smieszek, Mihael H. Polymeropoulos
31 [GO] 2021―Jul―07 Vaccine or Monoclonal therapy: which is winning weapon against COVID-19? Lorenzo Lo Muzio, Maria Eleonora Bizzoca
32 [GO] 2021―Jun―09 What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web-survey helps us understand where the doubts lie Marta Colaneri, Pietro Valsecchi, Marco Vecchia, Alessandro Di Filippo, Valentina Zuccaro, Elena Seminari, et al. (+6)
33 [GO] 2021―May―27 Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses Jeswin Joseph, T. Karthika, V.R. Akshay Das, V. Stalin Raj
34 [GO] 2021―Mar―01 AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic Jesús Rodríguez-Baño, Gian Maria Rossolini, Constance Schultsz, Evelina Tacconelli, Srinivas Murthy, Norio Ohmagari, et al. (+17)
35 [GO] 2021―Mar―01 Genomic Data Reveals the Emergence of IncQ1 Small Plasmid Carrying blaKPC-2 in Escherichia coli of the Pandemic Sequence Type 648 Bruna Fuga, Louise Cerdeira, Quézia Moura, Herrison Fontana, Danny Fuentes-Castillo, Albalúcia C. Carvalho, Nilton Lincopan
36 [GO] 2021―Jan―18 Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2 Alasdair MacGowan, Fergus Hamilton, Mark Bayliss, Liam Read, Marie Attwood, Alan Noel, et al. (+4)
37 [GO] 2020―Dec―29 Antiviral activity of interferon-based combination therapy in critically ill patients with Covid-19: preliminary observations Paolo Gaibani, Tommaso Tonetti, Michele Bartoletti, Maria Carla Re, PierLuigi Viale, V. Marco Ranieri
38 [GO] 2020―Dec―25 Treatment of a case with COVID-19 administering intravenous immunoglobulin Mustafa Çolak, Serdar Kalemci, Aydın Sarıhan
39 [GO] 2020―Dec―08 A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19) Sock Hoon Tan, Tat Ming Ng, Hui Lin Tay, Min Yi Yap, Shi Thong Heng, Audrey Yong Xin Loo, et al. (+2)
40 [GO] 2020―Dec―08 Remdesivir for the treatment of coronavirus COVID-19: a meta-analysis of randomised controlled trials Yuki Enoki, Yuki Igarashi, Yuki Watabe, Kyoka Honma, Yuto Suzuki, Yukitaka Hayashi, et al. (+3)
41 [GO] 2020―Nov―23 Cytokine storm of a different flavor: the different cytokine signature of SARS-CoV2 the cause of COVID-19 from the original SARS outbreak Daniel O. Griffin, Alexandra Jensen, Mushmoom Khan, Jessica Chin, Kelly Chin, Jennifer Saad, et al. (+3)
42 [GO] 2020―Nov―23 Carbapenem resistant Klebsiella pneumoniae in ICU-admitted COVID-19 Patients: Keep an eye on the ball G. Montrucchio, S. Corcione, G. Sales, A. Curtoni, F.G. De Rosa, L. Brazzi
43 [GO] 2020―Oct―29 INCIDENCE OF BACTERIAL AND FUNGAL BLOODSTREAM INFECTIONS IN COVID-19 PATIENTS IN INTENSIVE CARE: AN ALARMING “COLLATERAL EFFECT” Maria Adriana Cataldo, Nardi Tetaj, Marina Selleri, Luisa Marchioni, Alessandro Capone, Emanuela Caraffa, et al. (+2)
44 [GO] 2020―Oct―17 Ototoxicity prevention during the SARS-CoV-2 (Covid-19) emergency Andrea Ciorba, Piotr Henryk Skarżyński, Stefano Pelucchi, Stavros Hatzopoulos
45 [GO] 2020―Oct―13 A Possible Application of High Dose Vitamin C in the Prevention and Therapy for Coronavirus Infections Ba X. Hoang, D. Graeme Shaw, William Fang, Bo Han
46 [GO] 2020―Aug―20 A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: results of a retrospective observational study in the French overseas department of Reunion Island Arthur Dubernet, Kevin Larsen, Laurie Masse, Jérôme Allyn, Emilie Foch, Lea Bruneau, et al. (+14)
47 [GO] 2020―Aug―15 Neutrophil-to-lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients Shaghayegh Haghjooy Javanmard, Golnaz Vaseghi, Amir Reza Manteghi Nezhad, Maryam Nasirian
48 [GO] 2020―Aug―15 Usefulness of brochoalveolar lavage in suspect covid-19 repeatedly negative swab test and interstitial lung disease Jacopo Vannucci, Franco Ruberto, Daniele Diso, Gioacchino Galardo, Claudio M. Mastroianni, Giammarco Raponi, et al. (+6)
49 [GO] 2020―Aug―08 Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-COV-2 infection? Sudhir Mehta, Sudhir Bhandari, Shaurya Mehta
50 [GO] 2020―Aug―05 Hydroxychloroquine use in Hospitalized Patients with COVID-19: An observational matched cohort study Markos Kalligeros, Fadi Shehadeh, Eleftheria Atalla, Evangelia K. Mylona, Su Aung, Aakriti Pandita, et al. (+7)
51 [GO] 2020―Jul―25 Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care Lesley Heesom, Lucas Rehnberg, Myra Nasim-Mohi, Alexander I.R. Jackson, Michael Celinski, Ahilanadan Dushianthan, et al. (+3)
52 [GO] 2020―Jul―16 Could Bordetella pertussis vaccine protect against coronavirus COVID-19? Usama M. Alkholy, Mohamed E Salama, Hagar Mahmoud, Ahmed Taher, Khaled M. Elsayes
53 [GO] 2020―Jul―11 Perceived Challenges of COVID-19 Infection Prevention and Control Preparedness: A Multinational Survey Ermira Tartari, Joost Hopman, Benedetta Allegranzi, Bin Gao, Andreas Widmer, Vincent Chi-Chung Cheng, et al. (+4)
54 [GO] 2020―Jul―02 SARS-CoV-2 positivity in rectal swabs implication for possible transmission Federica Novazzi, Irene Cassaniti, Antonio Piralla, Antonio Di Sabatino, Raffaele Bruno, Fausto Baldanti
55 [GO] 2020―Jul―01 Azithromycin and SARS-CoV-2 infection: where we are now and where we are going Luis Gabriel Parra-Lara, Juan José Martínez-Arboleda, Fernando Rosso
56 [GO] 2020―Jun―12 The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic Anuradha Chowdhary, Amit Sharma
57 [GO] 2020―May―29 Vitamin D deficiency and COVID-19 pandemic Patrick Zemb, Peter Bergman, Carlos A. Camargo, Etienne Cavalier, Catherine Cormier, Marie Courbebaisse, et al. (+7)
58 [GO] 2020―Apr―27 Continues Renal Replacement Therapy (CRRT) With Disposable Hemoperfusion Cartridge: A Promising Option for Severe COVID-19 Farzaneh Dastan, Ali Saffaei, Seyed Mehdi Mortazavi, Hamidreza Jamaati, Nadia Adnani, Sasan Samiee Roudi, et al. (+3)
59 [GO] 2020―Mar―07 2019-novel coronavirus outbreak: A new challenge Tommaso Lupia, Silvia Scabini, Simone Mornese Pinna, Giovanni Di Perri, Francesco Giuseppe De Rosa, Silvia Corcione
 [1] 

59 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec